ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295466 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295466; 2) Community: the network communities that were significantly associated with the response to NSC 295466; 3) Molecule: the relationships between components within communities and NSC 295466; 4) MDR: the compounds that were significantly associated with the NSC 295466.

NSC Compound Enrichment Correlation
NSC 122750 GELDANAMYCIN 0.0366216145653018 0.34775037
NSC 283440 B633439K049 0.0366216145653018 0.39494241
NSC 100071 component of Halotex 0.0386895225700407 0.3628051
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0386895225700407 -0.081019373
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0386895225700407 0.27226302
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0386895225700407 0.31639688
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0386895225700407 -0.074711474
NSC 155693 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide 0.0386895225700407 -0.21963809
NSC 176503 Fastigilin B 0.0386895225700407 0.3650898
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0386895225700407 0.10494307
Total:164  Current:133    [First] [Prev] [Next] [Last]